EDIT
Price
$5.36
Change
-$0.10 (-1.83%)
Updated
Apr 24, 1:45 PM EST
7 days until earnings call
KOD
Price
$3.36
Change
+$0.03 (+0.90%)
Updated
Apr 24, 2:33 PM EST
19 days until earnings call
Ad is loading...

EDIT vs KOD ᐉ Comparison: Which is Better to Invest?

Header iconEDIT vs KOD Comparison
Open Charts EDIT vs KODBanner chart's image
Editas Medicine
Price$5.36
Change-$0.10 (-1.83%)
Volume$600
CapitalizationN/A
Kodiak Sciences
Price$3.36
Change+$0.03 (+0.90%)
Volume$400
CapitalizationN/A
View a ticker or compare two or three
EDIT vs KOD Comparison Chart

Loading...

EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KODDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
EDIT vs. KOD commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and KOD is a Hold.

COMPARISON
Comparison
Apr 24, 2024
Stock price -- (EDIT: $5.46 vs. KOD: $3.33)
Brand notoriety: EDIT and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 82% vs. KOD: 38%
Market capitalization -- EDIT: $449M vs. KOD: $175.38M
EDIT [@Biotechnology] is valued at $449M. KOD’s [@Biotechnology] market capitalization is $175.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $557.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, KOD is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 2 TA indicator(s) are bullish while KOD’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 2 bullish, 3 bearish.
  • KOD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KOD is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -6.67% price change this week, while KOD (@Biotechnology) price change was -14.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.45%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was +1265.13%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 31, 2024.

KOD is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
A.I.dvisor published
a Summary for KOD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EDIT($449M) has a higher market cap than KOD($175M). KOD YTD gains are higher at: 9.539 vs. EDIT (-46.101).
EDITKODEDIT / KOD
Capitalization449M175M257%
EBITDAN/AN/A-
Gain YTD-46.1019.539-483%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITKOD
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 6 days ago
88%
View a ticker or compare two or three
Ad is loading...
EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KODDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LONAX13.610.18
+1.34%
Longboard A
AWAAX20.040.24
+1.21%
AB Wealth Appreciation Strategy A
MNVAX28.190.33
+1.18%
Madison Investors A
AAAQX11.420.07
+0.62%
DWS RREEF Real Assets R
ENVAX16.44N/A
N/A
VanEck Environmental Sustainability A

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with NTLA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-2.50%
NTLA - EDIT
68%
Closely correlated
-1.37%
BEAM - EDIT
63%
Loosely correlated
-2.61%
AXON - EDIT
52%
Loosely correlated
+2.64%
VCYT - EDIT
49%
Loosely correlated
-0.10%
ALLO - EDIT
48%
Loosely correlated
-0.88%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with NTLA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-2.63%
NTLA - KOD
40%
Loosely correlated
-1.37%
STOK - KOD
40%
Loosely correlated
N/A
NUVB - KOD
40%
Loosely correlated
N/A
INZY - KOD
37%
Loosely correlated
+0.23%
SRPT - KOD
36%
Loosely correlated
+0.14%
More